Positrigo is a Swiss startup founded in 2018 with the slogan "Imaging Everyone." The company addresses the pressing issue of dementia in aging societies, which costs nearly a trillion USD worldwide per year. Despite treatments being on the horizon, an affordable and widely available diagnostic technique is still missing. Positrigo's brain positron emission tomography system offers functional brain imaging to everyone at a fraction of today’s cost. The latest investment in Positrigo came in the form of a grant investment on 28 April 2023 from Innosuisse. This demonstrates the confidence and support from notable organizations in the startup's potential to make a significant impact on the healthcare industry. As a result, Positrigo is poised to play a pivotal role in improving diagnostic capabilities for dementia, making brain imaging more accessible and cost-effective.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Grant | Unknown | 1 | 28 Apr 2023 | |
Series B | Fr.5.50M | 6 | Zürcher Kantonalbankand, ZKB Pharma Vision Fund +2 | 24 Oct 2022 |
Series A | €1.50M | 1 | 30 Jul 2021 | |
Grant | €2.20M | 1 | 10 Jul 2020 | |
Series A | Fr.3.90M | 5 | Zürcher Kantonal Bank, Great Spirit Ventures +1 | 10 Jul 2020 |
No recent news or press coverage available for Positrigo.